Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury
Clinical trial NCT00810940 · UNKNOWN
Trial details
- NCT number
- NCT00810940
- Sponsor
- Abela Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.